Furthermore plasma exchange (PLEX), preferably against plasma rather than albumin, could represent an alternative option for reducing the amount of circulating PF4/vaccine complexes and correcting hypofibrinogenemia [17]. The gene discussed is PF4; the disease is Hypofibrinogenemia.